A Real-World, Retrospective Cohort Study Comparing the Effectiveness of Cell-Based Quadrivalent, Inactive Influenza Vaccine (QIVc) Versus Egg-Based, Quadrivalent, Inactive Influenza Vaccine (QIVe) in Preventing Influenza-Like Illness (ILI)
Phase of Trial: Phase IV
Latest Information Update: 01 Dec 2018
Price : $35 *
At a glance
- Drugs Influenza vaccine (Optaflu) (Primary) ; Influenza virus vaccine
- Indications Flu-like symptoms; Influenza virus infections
- Focus Therapeutic Use
- 01 Dec 2018 New trial record
- 16 Nov 2018 According to a Seqirus media release, data from this study were presented at the recent National Foundation for Infectious Disease (NFID) 2018 Clinical Vaccinology Course.
- 16 Nov 2018 Results presented in a Seqirus media release.